Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis

Acta Paediatr. 1996 Dec;85(12):1426-32. doi: 10.1111/j.1651-2227.1996.tb13947.x.

Abstract

Essential fatty acid (EFA) deficiency is a predisposing factor for pulmonary infection with Staphylococcus aureus and Pseudomonas aeruginosa, the two major pathogenic microorganisms in cystic fibrosis (CF).

Objective: The goal of this study was to investigate the essential fatty acid status of CF patients from infancy to 20 years old.

Materials and methods: Plasma fatty acid profiles for phospholipid (PL) were determined for cord (n = 6), 4 months (n = 40), 16 months (n = 25), 3 y (n = 8), 5-10 y (n = 10), and 10-20 y (n = 10) aged CF patients and compared to their respective control; cord (n = 22), 1-36 months (n = 38) and adult (n = 100). Significance was established by Student's t-test (p < 0.05).

Results: The plasma PL fatty acid profile for all CF patients, except cord, revealed consistent deficiency in omega 3 and omega 6 EFAs. These deficiencies were most marked at infancy and more pronounced for patients with meconium ileus.

Conclusions and relevance: EFA deficiency may contribute to the predisposition of CF infants to develop respiratory disease and to the excess cytotoxic activity found in bronchoalveolar lavage fluid at 2 months of age in the majority of screened infants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Child, Preschool
  • Cystic Fibrosis / complications*
  • Fatty Acids, Essential / blood
  • Fatty Acids, Essential / deficiency*
  • Female
  • Humans
  • Infant
  • Lung Diseases / etiology*
  • Male
  • Pseudomonas Infections / etiology*
  • Staphylococcal Infections / etiology*

Substances

  • Fatty Acids, Essential